TET2 mutations were the strongest genetic predictor of TI-CH, enhanced monocyte migration to lung tumor cells, fuelled a myeloid-rich tumor microenvironment in mice, and resulted in the promotion of tumor organoid growth. This evidence concerns the gene TET2 and neoplasm.